large vestibular aqueduct syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Newborn deafness genetic screening with 15 mutation loci in 4 genetic deafness genes using the Crystal Core? Fifteen Genetic Deafness Gene Test Kit and microarray from January 2022 to December 2024 at the Deafness Genetic Laboratory of Beijing Tongren Hospital. (2) Individuals carry with SLC26A4 gene containing heterozygous, homozygous or compound heterozygous mutations were detected.
Exclusion criteria
Exclusion criteria: Individuals with mutations in the GJB2 and GJB3 genes or the mitochondrial 12SrRNA gene were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hearing loss;genotype; | — |
Secondary
| Measure | Time frame |
|---|---|
| Temporal CT or MRI of inner ear; | — |
Countries
China
Contacts
Beijing Tongren Hospital, Capital Medical University